The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...

Memory lapses aren't always caused by Alzheimer's. Depression, infections or even vitamin deficiencies may be the reason. The ...

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building ...

While momentous, the approval may also put a renewed spotlight on an enduring defect of the American healthcare system. An ...

Prompt and proper treatment of pediatric UTIs is crucial for a quick recovery and to prevent long-term complications. Thus, ...

Vasopressin is a hormone involved in metabolism, reproduction, and homeostasis. Learn about natural production and synthetic ...